Director, Solid Tumor Cell Therapy Program

NYU Langone Health is a fully integrated health system that consistently achieves the best patient outcomes through a rigorous focus on quality that has resulted in some of the lowest mortality rates in the nation. Vizient Inc. has ranked NYU Langone the No. 1 comprehensive academic medical center in the country for three years in a row, and U.S. News & World Report recently placed nine of its clinical specialties among the top five in the nation. NYU Langone offers a comprehensive range of medical services with one high standard of care across 6 inpatient locations, its Perlmutter Cancer Center, and over 320 outpatient locations in the New York area and Florida. With $14.2 billion in revenue this year, the system also includes two tuition-free medical schools, in Manhattan and on Long Island, and a vast research enterprise with over$1 billion in active awards from the National Institutes of Health. For more information, go to nyulangone.org, and interact with us on LinkedIn, Glassdoor, Indeed. More: NYU Grossman School of Medicine has trained thousands of physicians and scientists who have helped to shape the course of medical history since 1841. With more than 75 divisions of specialty care including comprehensive inpatient and outpatient programs for every stage of life, a multifaceted Research and Academic Center and the NYU Grossman Long Island School of Medicine focused on primary care, NYU Langone Hospital-Long Island joined NYU Langone Health as of August 1, 2019. At NYU Langone Hospitals, NYU Grossman School of Medicine, NYU Grossman Long Island School of Medicine and NYU Langone Health (collectively referred to as "NYU Langone"), we work collectively to achieve our mission: To care. To teach. To discover. We celebrate the inclusive excellence of the people that make us a world-class institution in patient care, education and science ("tripartite missions"). We strive to be a place where our exceptionally talented faculty, staff and students can thrive.